Effect of interventions during acute respiratory syncytial virus bronchiolitis on subsequent long term respiratory morbidity.
Khoshoo
Vikram
V
Department of Pediatrics, West Jefferson Medical Center, New Orleans, LA, USA. vkhoshoo@earthlink.net
Ross
Gerald
G
Edell
Dean
D
D000085:Acetates / Q000627:therapeutic use; D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001990:Bronchiolitis, Viral / Q000150:complications* / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003521:Cyclopropanes; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D007231:Infant, Newborn; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D009017:Morbidity; D011446:Prospective Studies; D011804:Quinolines / Q000627:therapeutic use; D018357:Respiratory Syncytial Virus Infections / Q000150:complications*; D012189:Retrospective Studies; D013440:Sulfides
D000085:Acetates; D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast; D004205:Cromolyn Sodium